Remove category agency-information
article thumbnail

News from the Consumer Technology Association and Withings Further Demonstrates Private Sector’s Role in the Pandemic and Public Health

Health Populi

This week, announcements from the Consumer Technology Association (CTA) and Withings further bolster the case for the private sector bolstering public health in this pandemic…and future ones to come beyond the Age of the Coronavirus. On 27th July, CTA announced the Association’s launch of the Public Health Tech Initiative.

article thumbnail

Part 2: Who Regulates Healthcare AI?

AIHC

AI is advancing rapidly, so we encourage you to reference the new Artificial Intelligence article category for the latest articles. The question remains, how will the use of AI be regulated for health care use? This article only scratches the surface of various regulatory agencies involved in the regulation of AI.

FDA 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

Eudralex, Volume 4: GMP Guidelines and Annexes Revision of the EU GMP Guide Annex 11 “Computerized Systems” – Presentation of Concept Paper, 18 November 2022 On 16 November 2022, the European Medicines Agency EMA published a concept paper on the planned revision of Annex 11 “Computerized Systems.”

article thumbnail

A Whole New World for Laboratory Developed Tests – FDA Proposes End to Its Longstanding Policy of Enforcement Discretion

Hall Render

On September 29, 2023, the Food and Drug Administration (“FDA”) announced the issuance of a Notice of Proposed Rulemaking (the “Proposed Rule”) to expand the FDA’s regulatory scope over in vitro diagnostics products (“IVDs”) to specifically address Laboratory Developed Tests (“LDTs”).

FDA 40
article thumbnail

Tackling Racially Biased Health Care Algorithms

Bill of Health

Addressing algorithmic bias at the federal level Following a promise by the Biden Administration in 2022 to conduct an “evidence-based examination of health care algorithms and racial and ethnic disparities,” the Agency for Healthcare Research and Quality (AHRQ), began a systematic review last year.

FDA 157
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

MDCG 2023-3 , Questions and Answers on Vigilance Terms and Concepts as Outlined in the Regulation (EU) 2017/745 on Medical Devices, provides additional information on key vigilance terms. The document will become effective 6 months after publication (10 September 2023). The written procedure for incident reporting was inadequate.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

This guidance will help applicants interpret how to implement Essential Principles of Medical Device Safety and Performance using information that was issued in March 2020. It will also facilitate cross-border circulation of these critical health therapies as well as cross-border cooperation between public health authorities.

FDA 40